Probiotics and Synbiotics for Glycaemic Control and Beta-Cell Function in Children with Type 1 Diabetes Mellitus: A Meta-Analysis of Randomised Controlled Trials
DOI:
https://doi.org/10.37275/oaijmr.v6i3.910Keywords:
Beta-cell function, Children, Glycaemic control, Probiotics, Type 1 diabetes mellitusAbstract
Gut dysbiosis has been implicated in the pathogenesis and progression of type 1 diabetes mellitus (T1DM), and microbiota-based interventions have been proposed as adjuncts to insulin. The paediatric evidence remains fragmented and the effect on residual beta-cell function has not been a focus. This meta-analysis quantified the effect of probiotic and synbiotic supplementation on glycated haemoglobin (HbA1c) and synthesised beta-cell and immune outcomes in children with T1DM. PubMed/MEDLINE was searched for randomised controlled trials (RCTs) of oral probiotics, prebiotics, or synbiotics added to insulin in T1DM, with HbA1c as the primary outcome. Standardised mean differences (SMD, Hedges’ g) were pooled with a random-effects model (DerSimonian–Laird). Subgroup, leave-one-out, an a-priori paediatric-only sensitivity, and exploratory small-study analyses were performed. Risk of bias used Cochrane RoB 2.0. Beta-cell and immune outcomes were synthesised narratively. Seven RCTs (453 participants) were included. Supplementation produced a significant, small-to-moderate reduction in HbA1c (pooled g = −0.50, 95% CI −0.71 to −0.30; z = −4.94, p < 0.0001), with low heterogeneity (I² = 11.0%, τ² = 0.008, Q = 6.74, df = 6, p = 0.345) and a prediction interval of −0.84 to −0.17, corresponding to about 0.3 to 0.5 HbA1c percentage points. The effect was consistent across disease stage (between-group p = 0.957), was preserved in the strictly paediatric analysis (g = −0.54), and was robust to leave-one-out removal. Beta-cell outcomes were inconsistent. Supplementation was safe. In conclusion, in children with T1DM, probiotics and synbiotics conferred a modest but consistent improvement in HbA1c, without convincing evidence of beta-cell preservation. The intervention appears safe but the clinical magnitude is small and does not currently justify a change to routine practice.
Authors
- Michael Theodore1*
- Salim Aljufri2
- Noviane Angrella1
- 1Faculty of Medicine, Universitas Hang Tuah, Surabaya, Indonesia
- 2Faculty of Medicine, Universitas Alkhairaat, Palu, Indonesia
Corresponding author Michael Theodore — theodore.michael1998@gmail.com
Downloads
Published
Issue
Section
License
Authors retain copyright in their articles and grant Open Access Indonesian Journal of Medical Reviews (OAIJMR) the non-exclusive right of first publication. Unless otherwise stated on an individual article, published work is licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (CC BY-NC-SA 4.0). Users may share and adapt the work for non-commercial purposes provided that appropriate attribution is given, changes are indicated, and adaptations are distributed under the same license. Copyright in the journal website, logo, layout, and other publisher-owned materials is separate from copyright in individual articles.
How to Cite
Article Metrics
Views and downloads recorded by this journal. Citation count from OpenAlex.